Dwi Hartati

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Nasopharyngeal carcinoma (NPC) is a rare disease in the Western world, but it is endemic in certain parts of Southeast Asia and China. During the last decades, the outcome of the treatment has improved considerably. Concurrent chemo-radiation has become the treatment of choice in advanced NPC. Five years survival figures of 80-90 % for T1-T2 and 60-80 % for(More)
  • 1